Treatment of autoimmune hepatitits according to the national, international recommendations and own experience
Journal Title: Гастроентерологія - Year 2018, Vol 52, Issue 4
Abstract
Autoimmune hepatitis (AIH) is rare liver pathology, but there is the increase in the number of patients over the last years. There is no unambiguous determination or clear pathognomonic criteria of AIH. A presence of autoantibodies, hypergammaglobulinemia, characteristic morphological changes and response to immunosuppressive therapy are inherent for AIH. Immunosupressive therapy must provide the control of autoimmune process, elimination of inflammatory syndrome, fibrosis reduction, slowing down the development of cirrhosis. The first-line drugs in AIH are corticosteroids and azathioprine, more effective than placebo. Prednisolone is prescribed at a dose of 40–60 mg/day, individual dose is 0.5–1 mg/kg/day. The higher the activity of cytolysis, the larger the required dose of prednisolone. When cytolysis is reduced according to hepatic tests, the dose of prednisolone is decreased. Methylprednisolone is used more often in practice. Azathioprine is administered either immediately or 2 weeks after prednisolone at a dose 50 mg/day with a possible increase to 100 mg/day, individual dose is 1–2 mg/kg/day. Now preference is given to combination therapy with prednisolone and azathioprine. Assessment of the effectiveness of AIH treatment involves monitoring the level of aminotransferases and immunoglobulin G, their complete normalization is desirable. To evaluate fibrosis, we used liver elastography. Treatment is actually life long. The second-line drugs are mycophenolate mofetil, cyclosporine, tacrolimus, sirolimus, everolimus and other. The mycophenolate mofetil is considered most studied. The search for effective AIG therapy continues, methods of cellular, anticytokine, antifibrotic therapies are being developed. Clinical examples from own experience are presented. Treatment of AIH is a difficult process. Modern recommendations, data from the studies and accumulated experience help considerably. The choice of therapy requires individual approach, taking into account the features of clinical course and response to therapy.
Authors and Affiliations
Yu. M. Stepanov, S. V. Kosynska
Keywords
Related Articles
- EP ID EP440852
- DOI 10.22141/2308-2097.52.4.2018.154146
- Views 92
- Downloads 0
The Role of Vegetative Dysfunction and Its Correction in Gastroesophageal Reflux Disease
The article analyzes the findings regarding the effect of vegetative dysfunction on the course of gastroesophageal reflux disease, the expediency of autonomic imbalance correction by phenibut on the background of antisec...
Immunological reactivity in patients with chronic diffuse liver diseases
Background. The aim of the study was to assess the state of the main indicators of cellular immunity and the level of cytokines in patients with chronic diffuse liver diseases (CDLD). Materials and methods. Sixty eight p...
Gastroenterological Care for Ukraine Population: Main Health Indicators and Provision of Resources in 2011
The article presents the characteristics of main health indicators of the population (prevalence, morbidity) in terms of chronic digestive diseases. There were analyzed the quantitative and qualitative components of gast...
Tactics and Surgical Treatment of Obstructive Jaundice of Different Etiology
In the department of surgery of the digestive organs of State institution «Institute of gastroenterology of National aca-demy of medical sciences of Ukraine» for the period from 2003 to 2013, 567 patients with pathology...
Features of Pathology of the Digestive System in Elderly and Senile Patients and Efficacy of Their Treatment
The author presented in the article the results of own study of elderly and senile patients with chronic abdominal ischemia, against which biliary dysfunction and functional constipation had been developed. In the treatm...